APEI Stock Forecast & Price Target

APEI is viewed favorably because its Military+ franchise holds the #1 position in active-duty military education with about 30% share, around 50% of 2025 consolidated revenue, and more than 100% of consolidated EBITDA, giving it a durable moat and steady, high-margin cash generation. The company also has meaningful growth optionality from Rasmussen and Hondros recovery, where enrollment and profitability are improving, while Health+ reached a multi-year EBITDA margin high of 4% in CY’25 and helped lift consolidated adj. EBITDA margins to 13.2% in CY’25 from 9.4% in 2022. Its balance sheet and execution have strengthened as well, supported by consistent free cash flow, average FCF conversion of 54% since 2016, and 1Q’26 results showing revenue of $174.7 million, adj. EBITDA of $29.2 million, and raised 2026 guidance.

APEI is facing a negative outlook because its core business remains vulnerable to regulatory compliance failures that could jeopardize accreditation, Title IV participation, DoD TA access, and VA benefits, all of which would pressure enrollment and tuition-driven revenue. Intense competition in the postsecondary market also threatens market share and raises student acquisition costs, while the need to continuously refresh coursework and programs creates execution risk that could weaken student retention and growth. Although Q2/26 revenue guidance of $170.0-$172.0 million suggests 5.1% year-over-year growth at the midpoint, diluted EPS of $0.34-$0.39 and adjusted EBITDA of $16.5-$18.0 million both fall below FactSet consensus, signaling limited profitability momentum.